Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Xylometazoline hydrochloride (substance) |
Is a |
False |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline adverse reaction |
Causative agent (attribute) |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to xylometazoline (finding) |
Causative agent (attribute) |
False |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline nasal solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing xylometazoline in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline- and xylometazoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to xylometazoline (finding) |
Causative agent (attribute) |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride (substance) |
Is modification of (attribute) |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing xylometazoline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing antazoline and xylometazoline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing cromoglicic acid and xylometazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Antazoline and xylometazoline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cromoglicic acid and xylometazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Xylometazoline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cromoglicic acid and xylometazoline only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only xylometazoline in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only xylometazoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only antazoline and xylometazoline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline 500 microgram/mL nasal spray |
Has precise active ingredient |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline 500 microgram/mL nasal spray |
Has basis of strength substance (attribute) |
True |
Xylometazoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |